Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 484 (LINC00484) is a long non-coding RNA that belongs to the class of long intergenic non-coding RNAs (lincRNAs)[1][3][4]. It is transcribed from a region of the genome that does not overlap with protein-coding genes. Like other lincRNAs, LINC00484 is presumed to play regulatory roles rather than encoding a protein[8]. While the general functional mechanisms of lincRNAs include recruitment of proteins to chromatin, participation in chromatin interactions, and potential regulation of transcription, the specific biological functions of LINC00484 are not well characterized in the current scientific literature[2]. LINC00484 has been associated in gene databases with certain rare metabolic disorders, but direct mechanistic evidence is lacking and its role as a therapeutic target is not established[4]. No drugs are known to interact with LINC00484, and there are no reported biomarkers or safety concerns related to its targeting in clinical contexts.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on long intergenic non-protein coding RNA 484 (LINC00484).